We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
A federal judge in New York has seized the assets of hundreds of persons and organisations, including two alleged “kingpins,” who are charged with running a scam to
Eisai and Biogen announced that the phase 3 confirmatory Clarity AD clinical trial of lecanemab in Alzheimer’s disease (AD) has met its primary endpoint, which is change from
American biotech company Seagen and Netherlands-based LAVA Therapeutics have signed an exclusive licensing deal worth up to $700m to develop, manufacture, and commercialise the latter’s LAVA-1223 for the
Pharmaceutical major Merck has prevailed in a patent infringement suit against US-based Viatris related to sitagliptin at the US District Court for the Northern District of West Virginia.
Pfizer and Sangamo Therapeutics have re-opened the recruitment for the phase 3 AFFINE study of giroctocogene fitelparvovec, an investigational gene therapy for patients having moderately severe to severe
Pharmaceutical company GSK and Microsoft have entered into a partnership with the Centre for Health and Disease Studies (CHDS) Nepal to initiate a disease surveillance project in Nepal.
CytoReason, an artificial intelligence (AI) based medical technology firm, and Pfizer have signed an extended multi-year deal worth up to $110m under which the pharma major will use
GENFIT, a US-based biopharma company, has agreed to acquire Swiss clinical-stage biotech company Versantis in a deal worth up to CHF105m ($109m). Versantis is focussed on developing drugs
bluebird bio has received US Food and Drug Administration (FDA) Accelerated Approval for Skysona to treat active cerebral adrenoleukodystrophy (CALD). According to the firm, Skysona (elivaldogene autotemcel), also
US-based biopharmaceutical company RIGImmune said that it has acquired Subintro, a biotechnology company engaged in developing antiviral therapeutics for respiratory diseases caused by RNA viruses. The financial terms